These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35421421)

  • 21. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
    Wang E; Papavassiliou P; Sebastian S
    Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) with CD30-positive lymphocyte-predominant (LP) cells.
    Seliem RM; Ferry JA; Hasserjian RP; Harris NL; Zukerberg LR
    J Hematop; 2011 Sep; 4(3):175. PubMed ID: 32288859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocyte nuclear factor 1β suppresses canonical Wnt signaling through transcriptional repression of lymphoid enhancer-binding factor 1.
    Chan SC; Hajarnis SS; Vrba SM; Patel V; Igarashi P
    J Biol Chem; 2020 Dec; 295(51):17560-17572. PubMed ID: 33453998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrasensitive RNA In Situ Hybridization for Kappa and Lambda Light Chains Assists in the Differential Diagnosis of Nodular Lymphocyte-predominant Hodgkin Lymphoma.
    Kaseb H; Wang Z; Cook JR
    Am J Surg Pathol; 2022 Aug; 46(8):1078-1083. PubMed ID: 35195576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonal relation in a case of CLL, ALCL, and Hodgkin composite lymphoma.
    van den Berg A; Maggio E; Rust R; Kooistra K; Diepstra A; Poppema S
    Blood; 2002 Aug; 100(4):1425-9. PubMed ID: 12149227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Richter syndrome: A rare complication of chronic lymphocytic leukemia or small lymphocytic lymphoma.
    Wąsik-Szczepanek E; Szymczyk A; Szczepanek D; Wszoła-Kleinrok J; Chocholska S; Pluta A; Hus M
    Adv Clin Exp Med; 2018 Dec; 27(12):1683-1689. PubMed ID: 30156387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice.
    Li C; Romero-Masters JC; Huebner S; Ohashi M; Hayes M; Bristol JA; Nelson SE; Eichelberg MR; Van Sciver N; Ranheim EA; Scott RS; Johannsen EC; Kenney SC
    PLoS Pathog; 2020 Jun; 16(6):e1008590. PubMed ID: 32542010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LEF1: a highly specific marker for the diagnosis of chronic lymphocytic B cell leukaemia/small lymphocytic B cell lymphoma.
    Menter T; Dirnhofer S; Tzankov A
    J Clin Pathol; 2015 Jun; 68(6):473-8. PubMed ID: 25713417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis.
    Broséus J; Hergalant S; Vogt J; Tausch E; Kreuz M; Mottok A; Schneider C; Dartigeas C; Roos-Weil D; Quinquenel A; Moulin C; Ott G; Blanchet O; Tomowiak C; Lazarian G; Rouyer P; Chteinberg E; Bernhart SH; Tournilhac O; Gauchotte G; Lomazzi S; Chapiro E; Nguyen-Khac F; Chery C; Davi F; Hunault M; Houlgatte R; Rosenwald A; Delmer A; Meyre D; Béné MC; Thieblemont C; Lichter P; Ammerpohl O; Guéant JL; ; Guièze R; Martin-Subero JI; Cymbalista F; Feugier P; Siebert R; Stilgenbauer S
    Nat Commun; 2023 Jan; 14(1):309. PubMed ID: 36658118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features.
    Rodig SJ; Ouyang J; Juszczynski P; Currie T; Law K; Neuberg DS; Rabinovich GA; Shipp MA; Kutok JL
    Clin Cancer Res; 2008 Jun; 14(11):3338-44. PubMed ID: 18519761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
    Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
    Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis.
    Gerber NK; Atoria CL; Elkin EB; Yahalom J
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):76-83. PubMed ID: 25863756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High LEF1 expression predicts adverse prognosis in chronic lymphocytic leukemia and may be targeted by ethacrynic acid.
    Wu W; Zhu H; Fu Y; Shen W; Miao K; Hong M; Xu W; Fan L; Young KH; Liu P; Li J
    Oncotarget; 2016 Apr; 7(16):21631-43. PubMed ID: 26950276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of fascin and JunB in distinguishing nodular lymphocyte predominant from classical lymphocyte-rich Hodgkin lymphoma.
    Bhargava P; Pantanowitz L; Pinkus GS; Pinkus JL; Paessler ME; Roullet M; Gautam S; Bagg A; Kadin ME
    Appl Immunohistochem Mol Morphol; 2010 Jan; 18(1):16-23. PubMed ID: 19550297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical Expression of Lymphoid Enhancer Binding Factor 1 in CD5-Positive Marginal Zone, Lymphoplasmacytic, and Follicular Lymphomas.
    Patel N; Durkin L; Bodo J; Hsi ED
    Am J Clin Pathol; 2020 Apr; 153(5):646-655. PubMed ID: 31953940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of LRF/Pokemon and NOTCH1 protein expression in the distinction between nodular lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma.
    Bohn O; Maeda T; Filatov A; Lunardi A; Pandolfi PP; Teruya-Feldstein J
    Int J Surg Pathol; 2014 Feb; 22(1):6-11. PubMed ID: 24326827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 9p24.1 Genetic Alteration and PD-L1 Expression Are Characteristic of De Novo and Methotrexate-associated Epstein-Barr Virus-positive Hodgkin Lymphoma, But Not Methotrexate-associated Hodgkin-like Lesions.
    Shiraiwa S; Kikuti YY; Carreras J; Kondo Y; Ohmachi K; Ogawa Y; Kawada H; Sato S; Gion Y; Sato Y; Nakamura N; Ando K
    Am J Surg Pathol; 2022 Aug; 46(8):1017-1024. PubMed ID: 35848760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma.
    Browne P; Petrosyan K; Hernandez A; Chan JA
    Am J Clin Pathol; 2003 Nov; 120(5):767-77. PubMed ID: 14608905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Shades of gray between large B-cell lymphomas and Hodgkin lymphomas: differential diagnosis and biological implications.
    Harris NL
    Mod Pathol; 2013 Jan; 26 Suppl 1():S57-70. PubMed ID: 23281436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution in the definition and diagnosis of the Hodgkin lymphomas and related entities.
    Tousseyn TA; King RL; Fend F; Feldman AL; Brousset P; Jaffe ES
    Virchows Arch; 2023 Jan; 482(1):207-226. PubMed ID: 36274093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.